首页> 外国专利> ADDITIONAL ORGANIC DOSE FORMS FOR THE SUBSIDIATED RELEASE OF SUBSTANCES OF SUBSTANCES AND SUBSTANCES

ADDITIONAL ORGANIC DOSE FORMS FOR THE SUBSIDIATED RELEASE OF SUBSTANCES OF SUBSTANCES AND SUBSTANCES

机译:物质和物质的受补贴发布的其他有机剂量形式

摘要

Controlled-release oral drug dosage forms that comprise a tablet or capsule containing a plurality of particles of a solid-state drug dispersed in a swellable/erodible polymer, such as poly(ethylene oxide) are described. Once ingested, the tablet or capsule disintegrates to disperse the particles within the stomach where they imbibe water to cause them to swell and promote retention in fed-mode-induced patients. As the gastric-retained dosage form gradually erodes, the drug is released in a controlled manner to the stomach for treatment of local disorders, and to the upper gastrointestinal tract where it becomes available for absorption in a controlled and therapeutic manner. Drug containing vesicles, such as liposomes or nanoparticles or enteric-coated drugs particles, can also be delivered to the gastrointestinal tract in a controlled manner using the gastric-retentive dosage forms of the present invention.
机译:描述了控释口服药物剂型,其包含片剂或胶囊剂,该片剂或胶囊剂包含分散在可溶胀/易蚀的聚合物例如聚环氧乙烷中的多个固态药物颗粒。摄入后,片剂或胶囊会崩解,使颗粒分散在胃中,在那里它们吸收水,从而使其膨胀并促进以进食方式诱发的患者体内的滞留。随着保留在胃中的剂型逐渐侵蚀,药物以可控方式释放到胃中以治疗局部疾病,并释放到上消化道,在该处可以以受控和治疗方式吸收。含有脂质的药物囊泡,例如脂质体或纳米颗粒或肠溶药物颗粒,也可以使用本发明的胃滞留剂型以受控方式递送至胃肠道。

著录项

  • 公开/公告号DE69727153D1

    专利类型

  • 公开/公告日2004-02-12

    原文格式PDF

  • 申请/专利权人 DEPOMED INC.;

    申请/专利号DE19976027153T

  • 发明设计人 SHELL W.;LOUIE-HELM JENNY;

    申请日1997-09-18

  • 分类号A61K9/22;A61K9/52;

  • 国家 DE

  • 入库时间 2022-08-21 22:40:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号